Literature DB >> 33573350

Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.

Li Wang1, Kilho Eom1, Taeyun Kwon2.   

Abstract

Self-aggregation of amyloid-β (Aβ) peptides has been known to play a vital role in the onset stage of neurodegenerative diseases, indicating the necessity of understanding the aggregation process of Aβ peptides. Despite previous studies on the aggregation process of Aβ peptides, the aggregation pathways of Aβ isoforms (i.e., Aβ40 and Aβ42) and their related structures have not been fully understood yet. Here, we study the aggregation pathways of Aβ40 and Aβ42, and the structures of Aβ40 and Aβ42 aggregates during the process, based on fluorescence and atomic force microscopy (AFM) experiments. It is shown that in the beginning of aggregation process for both Aβ40 and Aβ42, a number of particles (i.e., spherical oligomers) are formed. These particles are subsequently self-assembled together, resulting in the formation of different shapes of amyloid fibrils. Our finding suggests that the different aggregation pathways of Aβ isoforms lead to the amyloid fibrils with contrasting structure.

Entities:  

Keywords:  Alzheimer’s disease; aggregation mechanism; amyloid beta (Aβ), spherical oligomers; morphology

Mesh:

Substances:

Year:  2021        PMID: 33573350      PMCID: PMC7912290          DOI: 10.3390/biom11020198

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  23 in total

1.  Atomic view of a toxic amyloid small oligomer.

Authors:  Arthur Laganowsky; Cong Liu; Michael R Sawaya; Julian P Whitelegge; Jiyong Park; Minglei Zhao; Anna Pensalfini; Angela B Soriaga; Meytal Landau; Poh K Teng; Duilio Cascio; Charles Glabe; David Eisenberg
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

Review 2.  Unfolding the role of protein misfolding in neurodegenerative diseases.

Authors:  Claudio Soto
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

Review 3.  Inhibition of amyloid formation.

Authors:  Torleif Härd; Christofer Lendel
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

4.  Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.

Authors:  Laia Sánchez; Sergio Madurga; Tara Pukala; Marta Vilaseca; Carmen López-Iglesias; Carol V Robinson; Ernest Giralt; Natàlia Carulla
Journal:  J Am Chem Soc       Date:  2011-04-12       Impact factor: 15.419

Review 5.  Amyloid toxicity in Alzheimer's disease.

Authors:  Allison B Reiss; Hirra A Arain; Mark M Stecker; Nicolle M Siegart; Lora J Kasselman
Journal:  Rev Neurosci       Date:  2018-08-28       Impact factor: 4.353

6.  Nanoconfinement controls stiffness, strength and mechanical toughness of beta-sheet crystals in silk.

Authors:  Sinan Keten; Zhiping Xu; Britni Ihle; Markus J Buehler
Journal:  Nat Mater       Date:  2010-03-14       Impact factor: 43.841

7.  Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides.

Authors:  Georg Meisl; Xiaoting Yang; Erik Hellstrand; Birgitta Frohm; Julius B Kirkegaard; Samuel I A Cohen; Christopher M Dobson; Sara Linse; Tuomas P J Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-17       Impact factor: 11.205

8.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease.

Authors:  H Mori; K Takio; M Ogawara; D J Selkoe
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

9.  Amyloid β-Protein Assembly and Alzheimer's Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation.

Authors:  Nicholas J Economou; Maxwell J Giammona; Thanh D Do; Xueyun Zheng; David B Teplow; Steven K Buratto; Michael T Bowers
Journal:  J Am Chem Soc       Date:  2016-02-04       Impact factor: 15.419

10.  Complete aggregation pathway of amyloid β (1-40) and (1-42) resolved on an atomically clean interface.

Authors:  Peter Niraj Nirmalraj; Jonathan List; Shayon Battacharya; Geoffrey Howe; Liang Xu; Damien Thompson; Michael Mayer
Journal:  Sci Adv       Date:  2020-04-08       Impact factor: 14.136

View more
  2 in total

1.  Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.

Authors:  Donald N Ngwa; Alok Agrawal
Journal:  J Immunol       Date:  2022-08-17       Impact factor: 5.426

Review 2.  Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications.

Authors:  Niccolò Candelise; Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle; Valeria Manganelli; Tina Garofalo; Maurizio Sorice; Roberta Misasi
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.